SAUNDERS BRENT L (CIK 1268854) reported 13 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy BLCO (14,700 shares), Buy BLCO (14,700 shares), Sell BLCO (22,059 shares), Sell BLCO (24,649 shares), Buy BLCO (327,102 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 14,700 | $251,958 |
| 2026-03-10 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 14,700 | $0 |
| 2026-03-02 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Sell | 22,059 | $407,871 |
| 2026-03-02 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Sell | 24,649 | $451,077 |
| 2026-02-27 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 327,102 | $0 |
| 2026-02-25 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Sell | 65,444 | $1.2M |
| 2025-08-07 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Sell | 4,231 | $61,096 |
| 2025-06-18 | Beauty Health Co (SKIN) | Director | Buy | 73,051 | $0 |
| 2025-05-27 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 22,000 | $248,160 |
| 2025-05-27 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 22,000 | $0 |
| 2025-05-22 | ARS Pharmaceuticals, Inc. (SPRY) | Director | Buy | 120,000 | $121,200 |
| 2025-05-22 | ARS Pharmaceuticals, Inc. (SPRY) | Director | Sell | 120,000 | $1.7M |
| 2025-02-28 | Bausch & Lomb Corp (BLCO) | CEO and Chairman of the Board | Buy | 168,168 | $0 |
Source: SEC Form 4 filings · as of 2026-03-10